Progressive Care Inc. (RXMD) Financial Statements (2024 and earlier)

Company Profile

Business Address 1111 PARK CENTER BLVD.
MIAMI GARDENS, FL 33169
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,8957,0157,3527,4526,7437,348
Cash and cash equivalents7,8957,0157,3527,4526,7437,348
Receivables10,18510,1936,4782,2003,6722,793
Inventory, net of allowances, customer advances and progress billings3,0693,0051,6311,263713898
Inventory3,0693,0051,6311,263713898
Prepaid expense334258220227246353
Other undisclosed current assets    4,1232,0051,895
Total current assets:21,48320,47115,68215,26513,37913,287
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization222937455462
Operating lease, right-of-use asset427329368410446484
Property, plant and equipment3,2843,1682,7202,5572,5832,448
Intangible assets, net (including goodwill)15,12917,2291,4901,5021,5151,527
Goodwill7313,1441,3881,3881,3881,388
Intangible assets, net (excluding goodwill)14,39814,085102115127139
Deposits noncurrent assets393939   
Other undisclosed noncurrent assets    393939
Total noncurrent assets:18,90120,7944,6554,5534,6364,559
TOTAL ASSETS:40,38441,26520,33719,81918,01517,847
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12,15812,3778,1969,2607,3847,915
Accounts payable11,25611,2127,1907,9406,5176,068
Accrued liabilities331515356768366416
Other undisclosed accounts payable and accrued liabilities5716506505525011,432
Debt163166172215261253
Other undisclosed current liabilities170170184196200165
Total current liabilities:12,49112,7138,5539,6727,8458,333
Noncurrent Liabilities
Long-term debt and lease obligation1,1151,1491,1882,3672,2732,588
Long-term debt, excluding current maturities1,1101,1391,1732,3482,2492,199
Finance lease, liability 51015202432
Liabilities, other than long-term debt21418821524227915,854
Operating lease, liability214188215242279357
Derivative instruments and hedges, liabilities      15,854
Total noncurrent liabilities:1,3291,3371,4032,6092,55118,442
Total liabilities:13,82014,0509,95612,28110,39726,775
Equity
Equity, attributable to parent, including:26,56427,21510,3817,5387,618(8,928)
Common stock676767676763
Additional paid in capital60,88648,26430,05522,57522,52511,284
Accumulated deficit(34,389)(21,116)(19,741)(15,104)(14,974)(20,275)
Other undisclosed equity, attributable to parent  0000 
Total equity:26,56427,21510,3817,5387,618(8,928)
TOTAL LIABILITIES AND EQUITY:40,38441,26520,33719,81918,01517,847

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues 12,35911,55612,06310,57210,788
Cost of revenue (8,579)(7,997)(8,245)(7,303)(7,982)
Other undisclosed gross profit    (671)(138)(644)
Gross profit: 3,7813,5593,1473,1302,162
Operating expenses (5,139)(2,935)(3,133)(3,506)(4,032)
Operating income (loss): (1,358)62414(376)(1,870)
Nonoperating income (expense) (17)(5,261)(144)5,677(7,093)
Investment income, nonoperating 227   
Interest and debt expense (38)(5,206)(150) (524)
Income (loss) from continuing operations before equity method investments, income taxes: (1,413)(9,843)(280)5,301(9,486)
Other undisclosed income from continuing operations before income taxes 385,206150 524
Income (loss) from continuing operations: (1,375)(4,637)(130)5,301(8,963)
Loss before gain (loss) on sale of properties:(8,963)
Net income (loss) attributable to parent: (1,375)(4,637)(130)5,301(8,963)
Preferred stock dividends and other adjustments      (541)
Net income (loss) available to common stockholders, diluted: (1,375)(4,637)(130)5,301(9,504)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss): (1,375)(4,637)(130)5,301(8,963)
Comprehensive income (loss), net of tax, attributable to parent: (1,375)(4,637)(130)5,301(8,963)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: